- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02827136
Effect of Lidocaine Patch for Shoulder Pain in Laparoscopic Cholecystectomy
December 18, 2017 updated by: Ji Eun Kim, Ajou University School of Medicine
Ajou University School of Medicine
The primary purpose of this study is to investigate the effect of lidocaine patch on the shoulder pain score after end of surgery.
The secondary purpose of this study is to investigate the effect of lidocaine patch on the total number of analgesic request on ward.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
63
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Seoum
-
Suwon, Seoum, Korea, Republic of
- Department of Anesthesiology and Pain Medicine, Ajou University School of Medicine
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 85 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Laparoscopic cholecystectomy under general anesthesia
Exclusion Criteria:
- Infection, trauma, or bleeding on shoulder
- Allergy to lidocaine
- Chronic pain
- Renal dysfunction
- Liver dysfunction
- Seizure
- History of shoulder surgery
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: PREVENTION
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: QUADRUPLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: Patch group
Lidocaine patch and Hypafix
|
Appliance of Lidocaine patch and hypafix on both shoulder tip after anesthetic induction
|
|
PLACEBO_COMPARATOR: Control group
Just Hypafix
|
Appliance of hypafix on both shoulder tip after anesthetic induction
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Shoulder pain score
Time Frame: Change from baseline shoulder pain score up to 24 hr after end of surgery
|
Change from baseline shoulder pain score up to 24 hr after end of surgery
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Total number of analgesics request on ward
Time Frame: Up to postoperative day 3
|
Up to postoperative day 3
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
February 8, 2017
Primary Completion (ACTUAL)
September 27, 2017
Study Completion (ACTUAL)
September 27, 2017
Study Registration Dates
First Submitted
July 4, 2016
First Submitted That Met QC Criteria
July 7, 2016
First Posted (ESTIMATE)
July 11, 2016
Study Record Updates
Last Update Posted (ACTUAL)
December 19, 2017
Last Update Submitted That Met QC Criteria
December 18, 2017
Last Verified
December 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Digestive System Diseases
- Biliary Tract Diseases
- Gallbladder Diseases
- Physiological Effects of Drugs
- Molecular Mechanisms of Pharmacological Action
- Anti-Arrhythmia Agents
- Central Nervous System Depressants
- Peripheral Nervous System Agents
- Sensory System Agents
- Anesthetics
- Membrane Transport Modulators
- Anesthetics, Local
- Voltage-Gated Sodium Channel Blockers
- Sodium Channel Blockers
- Lidocaine
Other Study ID Numbers
- AJIRB-MED-OBS-16-076
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Gallbladder Diseases
-
National Cancer Institute (NCI)CompletedStage II Gallbladder Cancer | Stage IIIA Gallbladder Cancer | Stage IIIB Gallbladder Cancer | Stage IVA Gallbladder Cancer | Stage IVB Gallbladder CancerUnited States
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)Active, not recruitingStage II Gallbladder Cancer AJCC v8 | Stage IIA Gallbladder Cancer AJCC v8 | Stage IIB Gallbladder Cancer AJCC v8 | Stage III Gallbladder Cancer AJCC v8 | Stage IIIA Gallbladder Cancer AJCC v8 | Stage IIIB Gallbladder Cancer AJCC v8United States
-
Emory UniversityWithdrawnStage II Gallbladder Cancer AJCC v8 | Stage IIA Gallbladder Cancer AJCC v8 | Stage IIB Gallbladder Cancer AJCC v8 | Stage III Gallbladder Cancer AJCC v8 | Stage IIIA Gallbladder Cancer AJCC v8 | Stage IIIB Gallbladder Cancer AJCC v8 | Stage I Gallbladder Cancer AJCC v8United States
-
Aswan UniversityCompletedAcute Calculous Cholecystitis | Gallbladder Empyema | Gallbladder MucoceleEgypt
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruitingUnresectable Gallbladder CancerChina
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityNot yet recruitingUnresectable Gallbladder CancerChina
-
King Chulalongkorn Memorial HospitalCompletedDisorders of Gallbladder, Biliary Tract and PancreasThailand
-
Sanjay Gandhi Postgraduate Institute of Medical...American Society of Clinical OncologyRecruitingGallbladder Cancer UnresectableIndia
-
Massachusetts General HospitalSanofi; Dana-Farber Cancer Institute; Beth Israel Deaconess Medical Center; Genentech... and other collaboratorsCompletedBiliary Tract Cancer | Gallbladder AdenocarcinomaUnited States
-
Prince of Songkla UniversityCompletedDisorders of Gallbladder, Biliary Tract and PancreaseThailand
Clinical Trials on Lidocaine patch and hypafix
-
Fayoum UniversityNot yet recruitingImpacted Third Molar Tooth
-
Aswan University HospitalUnknownCesarean Section ComplicationsEgypt
-
CRI LifetreeNuvo Research Inc.Completed
-
Scilex Pharmaceuticals, Inc.Completed
-
Corporacion Parc TauliCompletedDiabetic Neuropathy | Diabetic Nerve Problems | Diabetic Complications NeurologicalPakistan
-
Scilex Pharmaceuticals, Inc.Completed
-
Scilex Pharmaceuticals, Inc.Completed
-
Oregon Health and Science UniversityCompleted
-
Scilex Pharmaceuticals, Inc.Completed
-
Scilex Pharmaceuticals, Inc.Completed